KLK3 and prostate carcinoma: We found that a nadir PSA >0.5 ng/mL after completion of ≥7560 cGy +/- androgen deprivation was associated with a higher risk of biochemical failure, distant metastatic failure, prostate cancer-specific mortality, and all-cause mortality.